Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
|
Scientific Industries, Inc. (Name of Issuer) |
Common Stock, $0.05 par value (Title of Class of Securities) |
808757108 (CUSIP Number) |
Bleichroeder LP 1345 Avenue of the Americas, 47th Floor, New York, NY, 10105 (212) 698-3101 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
04/18/2025 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.


The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
CUSIP No. | 808757108 |
1 |
Name of reporting person
Bleichroeder LP | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
AF | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
DELAWARE
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
2,965,026.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
22.69 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IA |
SCHEDULE 13D
|
CUSIP No. | 808757108 |
1 |
Name of reporting person
Bleichroeder Holdings LLC | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
AF | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
DELAWARE
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
2,965,026.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
22.69 % | ||||||||
14 | Type of Reporting Person (See Instructions)
HC |
SCHEDULE 13D
|
CUSIP No. | 808757108 |
1 |
Name of reporting person
Andrew Gundlach | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
![]() ![]() | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
AF | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
![]() | ||||||||
6 | Citizenship or place of organization
UNITED STATES
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
2,965,026.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
![]() | ||||||||
13 | Percent of class represented by amount in Row (11)
22.69 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
Item 3. | Source and Amount of Funds or Other Consideration |
Item 3 is hereby amended to include the following: On April 18, 2025, the Issuer entered into a Securities Purchase Agreement (the "Purchase Agreement") with, among other persons, funds managed by the Reporting Persons providing for the issuance and sale, for an aggregate purchase price of $250,000, of 250,000 Shares and Warrants to purchase 250,000 Shares at an exercise price of $1.00 per Share. | |
Item 5. | Interest in Securities of the Issuer |
(a) | Item 5 is hereby amended to include the following: As of the date of this Schedule 13D, the Reporting Persons beneficially own 2,965,026 Shares, representing 22.69% of the outstanding Shares (including Shares that will be issuable upon the exercise of the Warrants). The percentages used herein are based upon (i) the 10,503,599 Shares reported as outstanding as of March 27, 2025 by the Issuer in its Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2025, (ii) the 1,050,000 Shares issued on April 18, 2025 as reported by the Issuer in its 8-K filed with the Securities and Exchange Commission on April 22, 2025 and (iii) the 1,511,675 Shares issuable upon the exercise of the Warrants. |
(b) | The Reporting Persons have sole voting and dispositive power over 2,965,026 Shares. |
(c) | Except as set forth in Item 3, the Reporting Persons have not affected any transaction in the Shares during the past sixty days. |
(d) | No person other than the Reporting Persons and the managed accounts or funds which hold the Shares is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares. |
(e) | Not applicable. |
Item 7. | Material to be Filed as Exhibits. |
Exhibit 99.1: Introductory Statement |
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|